Skip to search formSkip to main contentSkip to account menu

NB1011

Known as: NB 1011, NB101.1 
A novel small molecule, and a phosphoramidate derivative of (E)-5-(2-bromovinyl)-2'-deoxyuridine with antitumor property. NB1011 is selectively… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Hepatitis C virus is an infectious disease affecting millions of people worldwide and causing chronic liver disease. The current… 
2005
2005
The phosphoramidate technology we have developed has been recently applied to BVdU, leading to NB1011 (NewBiotics Inc… 
2004
2004
3144 Background: Resistance to fluoropyrimidines (FP) is associated with increased expression of TS. N is a pronucleotide analog… 
2003
2003
To develop a shelf-stable formulation of a cancer treatment under study, the authors evaluated three approaches: cosolvent… 
2002
2002
NB1011, a novel anticancer agent, targets tumor cells expressing high levels of thymidylate synthase (TS). NB1011 is converted… 
2002
2002
NB1011, a phosphoramidate derivative of (E)-5-(2-bromovinyl)-2'-deoxyuridine, is a novel small molecule anticancer agent. NB1011… 
2001
2001
Tumor cell resistance to fluoropyrimidines and other inhibitors of thymidylate synthase (TS) is a serious problem often…